Literature DB >> 19927517

The morbidity of trauma nephrectomy.

Norma M Edwards1, Jeffrey A Claridge, Raquel M Forsythe, Jordan A Weinberg, Martin A Croce, Timothy C Fabian.   

Abstract

Mortality has been shown to be high in patients after trauma nephrectomy (TN). However, there are little data regarding morbidity in survivors. The objective of this study was to determine the morbidity rates associated with TN with attention directed to renal failure (RF) and formation of intra-abdominal abscess (IAA). Patients who underwent TN over a 9-year period (1996 to 2004) were identified from the trauma registry. Records were reviewed for all complications after TN in patients surviving at least 48 hours. Eighty-nine patients were identified with TN; 61 per cent resulted after penetrating trauma. Overall mortality was 34 per cent. Seventy-one patients survived greater than 48 hours; 51 (72%) experienced at least one morbidity. There was no difference in morbidity rates between patients undergoing blunt trauma and those undergoing penetrating trama. Patients with morbidities were significantly older, more severely injured, and had higher mortality rates and longer hospital courses. Infectious complications were seen in 52 per cent, respiratory in 48 per cent, gastrointestinal in 30 per cent, coagulopathy in 25 per cent, and RF and IAA were each seen in 14 per cent of patients. Patients undergoing TN are severely injured with significant morbidity. The results from this study allow us to establish benchmarks to assess complication rates for patients who undergo TN, which can provide prognostic information and goals to improve patient outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19927517     DOI: 10.1177/000313480907501118

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  1 in total

1.  Nephrectomy is Associated with Increased Mortality after Renal Trauma: An Analysis of the National Trauma Data Bank from 2007-2016.

Authors:  Ross E Anderson; Sorena Keihani; Rupam Das; Heidi A Hanson; Marta L McCrum; James M Hotaling; Jeremy B Myers
Journal:  J Urol       Date:  2020-10-06       Impact factor: 7.450

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.